MEI Pharma Inc (MEIP) — Cash Flow Quality Index
MEI Pharma Inc (MEIP) has a Cash Flow Quality Index of -0.33x as of September 2023. Operating cash flow of $-18.49 Million is below net income of $56.37 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash efficiency ratio of MEI Pharma Inc to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
MEI Pharma Inc Cash Flow Quality Index (2017–2024)
Historical Cash Flow Quality Index for MEI Pharma Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check MEIP capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for MEI Pharma Inc (2017–2024)
Year-by-year earnings quality comparison for MEI Pharma Inc. For live market cap and the full company financial profile, see market cap of MEI Pharma Inc.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -2.84x | $-50.47 Million | $17.78 Million | ▼ -317.5% |
| 2017 | 1.31x | $3.49 Million | $2.67 Million | — |